Javad Shahidi is Chief Medical Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 158,932 shares of CNTA, which is worth approximately $2.7 Million. The most recent transaction as insider was on Oct 03, 2022, when has been sold 3,341 shares (Ordinary Shares) at a price of $3.95 per share, resulting in proceeds of $13,197. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 159K
0% 3M change
0% 12M change
Total Value Held $2.7 Million

Javad Shahidi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 03 2022
SELL
Open market or private sale
$13,197 $3.95 p/Share
3,341 Reduced 2.06%
158,932 Ordinary Shares
Sep 30 2022
SELL
Open market or private sale
$11,099 $4.07 p/Share
2,727 Reduced 1.65%
162,273 Ordinary Shares
Jul 01 2022
BUY
Grant, award, or other acquisition
-
165,000 Added 50.0%
165,000 Ordinary Shares
JS

Javad Shahidi

Chief Medical Officer
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA